Announcement
23 Oct 2026
: M42 and Inocras announce strategic collaboration to advance earlier detection of cancer recurrence in the UAE using whole genome powered MRD technology
Learn More

Using Liquid Biopsy as a Population Health Screening Tool

20 February 2025
Genomics and Precision Medicine
Arab Health 2025

About the Speakers

  • Dr. Lawrence Petalidis
    PhD, Head of Global Partnerships for M42
  • Dr. Budour Alkaf
    Senior Bioinformatician for M42. H.E
  • Dr. Budoor Ahmed Al Shehhi
    Section Head Chronic Conditions, Abu Dhabi Public Health Center

  • David Mullarkey
    Chief Executive Officer for ClearNote Health
  • Amir Ali Talasaz
    Co-CEO Guardant Health

    Watch Next